Human Genome Epidemiology Literature Finder
|
Records 1 - 18 (of 18 Records) |
| Query Trace: Leukemia and SLC22A1[original query] |
|---|
| OCT1 (SLC22A1) R61C polymorphism and response to imatinib treatment in chronic myeloid leukemia patients. Leukemia & lymphoma 2008 Nov 49 (11): 2222-3. Zach Otto, Krieger Otto, Foedermayr Mathilde, Zellhofer Barbara, Lutz Diet |
| Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Jul 15 (14): 14. Kim DH, Sriharsha L, Xu W, Kamel-Reid S, Liu X, Siminovitch K, Messner HA, Lipton JH |
| Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia. Journal of human genetics 2010 Nov 55 (11): 731-7. Takahashi Naoto, Miura Masatomo, Scott Stuart A, Kagaya Hideaki, Kameoka Yoshihiro, Tagawa Hiroyuki, Saitoh Hirobumi, Fujishima Naohito, Yoshioka Tomoko, Hirokawa Makoto, Sawada Kenic |
| Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia. Therapeutic drug monitoring 2011 Apr 33 (2): 244-50. Yamakawa Yuji, Hamada Akinobu, Nakashima Reiko, Yuki Misato, Hirayama Chie, Kawaguchi Tatsuya, Saito Hideyu |
| Association of SLCO1B3 polymorphism with intracellular accumulation of imatinib in leukocytes in patients with chronic myeloid leukemia. Biological & pharmaceutical bulletin 2011 34 (1): 114-9. Nambu Takeru, Hamada Akinobu, Nakashima Reiko, Yuki Misato, Kawaguchi Tatsuya, Mitsuya Hiroaki, Saito Hideyu |
| SLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in Asian patients with chronic myeloid leukemia. PloS one 2012 7 (12): 12. Singh O, Chan JY, Lin K, Heng CC, Chowbay B |
| Instability of mRNA expression signatures of drug transporters in chronic myeloid leukemia patients resistant to imatinib. Oncology reports 2013 Feb 29 (2): 741-50. Gromicho Marta, Magalhães Marta, Torres Fátima, Dinis Joana, Fernandes Alexandra R, Rendeiro Paula, Tavares Purificação, Laires António, Rueff José, Sebastião Rodrigues Antón |
| Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013 Mar 24 (3): 756-60. Seong S J, Lim M, Sohn S K, Moon J H, Oh S-J, Kim B S, Ryoo H M, Chung J S, Joo Y D, Bang S M, Jung C W, Kim D H, Park S Y, Yoon S S, Kim I, Lee H G, Won J H, Min Y H, Cheong J W, Park J S, Eom K S, Hyun M S, Kim M K, Kim H, Park M R, Park J, Kim C S, Kim H J, Kim Y K, Park E K, Zang D Y, Jo D Y, Lee H W, Yoon Y |
| ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib. Oncology letters 2014 Apr 7 (4): 1313-1319. Vivona Douglas, Lima Luciene Terezina, Rodrigues Alice Cristina, Bueno Carolina Tosin, Alcantara Greyce Kelly Steinhorst, Barros Luiza Saldanha Ribeiro, DE Moraes Hungria Vania Tiestsche, Chiattone Carlos Sérgio, DE Lourdes Lopes Ferrari Chauffaille Maria, Guerra-Shinohara Elvira Mar |
| Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. Medical oncology (Northwood, London, England) 2014 Mar 31 (3): 851. de Lima Luciene Terezina, Vivona Douglas, Bueno Carolina Tosin, Hirata Rosario D C, Hirata Mario H, Luchessi André D, de Castro Fabíola Attié, de Lourdes F Chauffaille Maria, Zanichelli Maria A, Chiattone Carlos S, Hungria Vania T M, Guerra-Shinohara Elvira |
| Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells. The pharmacogenomics journal 2015 Aug 15 (4): 363-71. Arimany-Nardi C, Montraveta A, Lee-Vergés E, Puente X S, Koepsell H, Campo E, Colomer D, Pastor-Anglada |
| Molecular Response to Imatinib and Its Correlation with mRNA Expression Levels of Imatinib Influx Transporter (OCT1) in Indian Chronic Myeloid Leukemia Patients. Asian Pacific journal of cancer prevention : APJCP 2017 8 18 (8): 2043-2048. Chhikara S, Sazawal S, Seth T, Chaubey R, Singh K, Sharma R, Mishra P, Mahapatra M, Saxena |
| hOCT1 gene expression predict for optimal response to Imatinib in Tunisian patients with chronic myeloid leukemia. Cancer chemotherapy and pharmacology 2017 Mar . Ben Hassine Islem, Gharbi Hanene, Soltani Ismail, Teber Mouheb, Farrah Ahlem, Ben Hadj Othman Hind, Amouri Hassiba, Bellaaj Hatem, Lakhal Rayhane Ben, Romdhane Neila Ben, Abbes Salem, Menif Sam |
| Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis. Pharmacological research 2018 Feb . Cargnin Sarah, Ravegnini Gloria, Soverini Simona, Angelini Sabrina, Terrazzino Salvato |
| The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients. Archives of medical science : AMS 2018 Oct 14 (6): 1416-1423. Belohlavkova Petra, Vrbacky Filip, Voglova Jaroslava, Racil Zdenek, Zackova Daniela, Hrochova Katerina, Malakova Jana, Mayer Jiri, Zak Pav |
| Association of SLC22A1,SLCO1B3 Drug Transporter Polymorphisms and Smoking with Disease Risk and Cytogenetic Response to Imatinib in Patients with Chronic Myeloid Leukemia. Laboratory medicine 2021 Jun . Mohammadi Fatemeh, Rostami Golale, Assad Dlnya, Shafiei Mohammad, Hamid Mohammad, Jalaeikhoo Has |
| The Role of SLC22A1 and Genomic Ancestry on Toxicity during Treatment in Children with Acute Lymphoblastic Leukemia of the Amazon Region. Genes 2022 4 13 (4): . Fernandes Sweny de S M, Leitão Luciana P C, Cohen-Paes Amanda de N, Gellen Laura P A, Pastana Lucas F, de Carvalho Darlen C, Modesto Antônio A C, da Costa Ana C A, Wanderley Alayde V, Lima Carlos H V de, Pereira Esdras E B, Fernandes Marianne R, Burbano Rommel M R, de Assumpção Paulo P, Santos Sidney E B Dos, Santos Ney P C D |
| Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients. Journal of clinical medicine 2022 10 11 (20): . Estrada Natalia, Zamora Lurdes, Ferrer-Marín Francisca, Palomo Laura, García Olga, Vélez Patricia, De la Fuente Iris, Sagüés Miguel, Cabezón Marta, Cortés Montserrat, Vallansot Rolando Omar, Senín-Magán María Alicia, Boqué Concepción, Xicoy Blan |
- Page last reviewed:Feb 1, 2024
- Content source: